SIG
BIO icon

Senator Investment Group’s Bio-Rad Laboratories Class A BIO Stock Holding History

Senator Investment Group’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-86,500
Closed -$10.7M – 62
2013
Q4 		$10.7M Sell
86,500
-444,500
-84% -$54.2M 0.12% 66
2013
Q3 		$62.4M Buy
531,000
+21,000
+4% +$2.48M 0.9% 43
2013
Q2 		$57.2M Buy
+510,000
New +$59.8M 0.89% 41

Other funds holding BIO

ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
LCS
Levin Capital Strategies New York $1.49B AUM 30.44% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Senator Investment Group's BIO Position: Q1 2014 in Review

Senator Investment Group sold out of Bio-Rad Laboratories Class A (BIO) in Q1 2014, closing a stake of 86,500 shares — an estimated $10.7M sold.

Senator Investment Group first reported a position in BIO in Q2 2013 and held it in 3 quarters. The position peaked at $62.4M in Q3 2013. 193 funds tracked by Wall St. Rank hold BIO as of Q1 2014.

  • Senator Investment Group reported no remaining Bio-Rad Laboratories Class A position as of Q1 2014 after selling out during the quarter.
  • Senator Investment Group sold 86,500 Bio-Rad Laboratories Class A shares in Q1 2014, an estimated $10.7M.
  • Senator Investment Group first reported a position in Bio-Rad Laboratories Class A in Q2 2013 and held it in 3 quarters.
  • Senator Investment Group's Bio-Rad Laboratories Class A position peaked at $62.4M in Q3 2013.
  • 193 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q1 2014.

Based on Senator Investment Group's 13F filing for Q1 2014, filed 15 May 2014.